Skip to main content
SpringerLink
Log in

Symptoms and Work-Up

  • Chapter
  • First Online:
Management of Urothelial Carcinoma

  • 531 Accesses

Abstract

The diagnostic process of bladder cancer consists of checking the medical history, urine cytology, cystoscopic exam, and imaging work-up. Cystoscopic exam and urinary cytology played the most important role; however, medical history is also important for diagnosis. Hematuria is the most common symptom of bladder cancer. About 90% of bladder cancer patients present with hematuria at the time of diagnosis, which is either gross or microscopic. Gross hematuria is more strongly correlated with advanced bladder cancer. Some of the lower urinary tract symptoms, such as dysuria, frequency, and urgency, are reported in 20% of bladder cancer patients and possible indicators of carcinoma in situ (CIS).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pashos CL, Botteman MF, Laskin BL, Redaelli A. Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract. 2002;10:311–22. https://doi.org/10.1046/j.1523-5394.2002.106011.x.

    Article  PubMed  Google Scholar 

  2. Ramirez D, Gupta A, Canter D, Harrow B, Dobbs RW, Kucherov V, et al. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer. BJU Int. 2016;117:783–6. https://doi.org/10.1111/bju.13345.

    Article  PubMed  Google Scholar 

  3. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 2000;163:524–7. https://doi.org/10.1016/S0022-5347(05)67916-5.

    Article  CAS  PubMed  Google Scholar 

  4. Jones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ. 2007;334:1040. https://doi.org/10.1136/bmj.39171.637106.AE.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Krogsbøll LT, Jørgensen KJ, Gøtzsche PC. Screening with urinary dipsticks for reducing morbidity and mortality. Cochrane Database Syst Rev. 2015;1:CD010007. https://doi.org/10.1002/14651858.CD010007.pub2.

    Article  PubMed  Google Scholar 

  6. Bangma CH, Loeb S, Busstra M, Zhu X, El Bouazzaoui S, Refos J, et al. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers. Eur Urol. 2013;64:41–7. https://doi.org/10.1016/j.eururo.2013.02.036.

    Article  PubMed  Google Scholar 

  7. Steiner H, Bergmeister M, Verdorfer I, Granig T, Mikuz G, Bartsch G, et al. Early results of bladder-cancer screening in a high-risk population of heavy smokers. BJU Int. 2008;102:291–6. https://doi.org/10.1111/j.1464-410X.2008.07596.x.

    Article  PubMed  Google Scholar 

  8. Tu WH, Shortliffe LD. Evaluation of asymptomatic, atraumatic hematuria in children and adults. Nat Rev Urol. 2010;7:189–94. https://doi.org/10.1038/nrurol.2010.27.

    Article  PubMed  Google Scholar 

  9. Buteau A, Seideman CA, Svatek RS, Youssef RF, Chakrabarti G, Reed G, et al. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up. Urol Oncol Semin Orig Investig. 2014;32:128–34. https://doi.org/10.1016/j.urolonc.2012.07.001.

    Article  Google Scholar 

  10. Mungan NA, Kiemeney LA, Van Dijck JA, Van Der Poel HG, Witjes JA. Gender differences in stage distribution of bladder cancer. Urology. 2000;55:368–71. https://doi.org/10.1016/S0090-4295(99)00481-1.

    Article  CAS  PubMed  Google Scholar 

  11. Garg T, Pinheiro LC, Atoria CL, Donat SM, Weissman JS, Herr HW, et al. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol. 2014;192:1072–7. https://doi.org/10.1016/j.juro.2014.04.101.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009;115:68–74. https://doi.org/10.1002/cncr.23986.

    Article  PubMed  Google Scholar 

  13. Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188:2473–81. https://doi.org/10.1016/j.juro.2012.09.078.

    Article  PubMed  Google Scholar 

  14. Sharp VJ, Barnes KT, Erickson BA. Assessment of asymptomatic microscopic hematuria in adults. Am Fam Physician. 2013;88:747–54. https://doi.org/10.1016/S1002-0721(12)60414-1.

    Article  CAS  PubMed  Google Scholar 

  15. Horie S, Ito S, Okada H, Kikuchi H, Narita I, Nishiyama T, et al. Japanese guidelines of the management of hematuria 2013. Clin Exp Nephrol. 2014;18:679–89. https://doi.org/10.1007/s10157-014-1001-2.

    Article  PubMed  Google Scholar 

  16. Brigden ML, Edgell D, McPherson M, Leadbeater A, Hoag G. High incidence of significant urinary ascorbic acid concentrations in a west coast population--implications for routine urinalysis. Clin Chem. 1992;38:426–31.

    CAS  PubMed  Google Scholar 

  17. Rao PK, Gao T, Pohl M, Jones JS. Dipstick pseudohematuria: unnecessary consultation and evaluation. J Urol. 2010;183:560–5. https://doi.org/10.1016/j.juro.2009.10.049.

    Article  PubMed  Google Scholar 

  18. Pow-Sang JM, Seigne JD. Contemporary management of superficial bladder cancer. Cancer Control. 2000;7:335–9. https://doi.org/10.1177/107327480000700402.

    Article  CAS  PubMed  Google Scholar 

  19. Tissot WD, Diokno AC, Peters KM. A referral center’s experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol. 2004;172:478–80. https://doi.org/10.1097/01.ju.0000132323.89037.73.

    Article  PubMed  Google Scholar 

  20. Large MC, Cohn JA, Steinberg GD. Optimal risk-adapted surveillance strategies for NMIBC, including upper tract imaging. Urol Clin North Am. 2013;40:305–15. https://doi.org/10.1016/j.ucl.2013.01.013.

    Article  PubMed  Google Scholar 

  21. Cowan NC. CT urography for hematuria. Nat Rev Urol. 2012;9:218–26. https://doi.org/10.1038/nrurol.2012.32.

    Article  CAS  PubMed  Google Scholar 

  22. Jinzaki M, Tanimoto A, Shinmoto H, Horiguchi Y, Sato K, Kuribayashi S, et al. Detection of bladder tumors with dynamic contrast-enhanced MDCT. Am J Roentgenol. 2007;188:913–8. https://doi.org/10.2214/AJR.06.0511.

    Article  Google Scholar 

  23. Woldu SL, Bagrodia A, Lotan Y. Guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 2017;119:371–80. https://doi.org/10.1111/bju.13760.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Babjuk M, Böhle A, Burger M, Compérat E, Kaasinen E, Palou J, et al. EAU guidelines on non-muscle-invasive bladder cancer (Ta, T1 and CIS). Eur Assoc Urol. 2016. http://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/.

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Seoul National University Hospital, Seoul, South Korea

    Jungyo Suh

Authors
  1. Jungyo Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Seoul National University Hospital, Seoul, Korea (Republic of)

    Ja Hyeon Ku

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Suh, J. (2019). Symptoms and Work-Up. In: Ku, J. (eds) Management of Urothelial Carcinoma. Springer, Singapore. https://doi.org/10.1007/978-981-10-5502-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5502-7_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5501-0

  • Online ISBN: 978-981-10-5502-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation